Fig. 1From: Eicosapentaenoic acid ethyl ester improves endothelial dysfunction in type 2 diabetic micePlasma glucose (a), insulin (b), total cholesterol (c), and triglyceride (d) levels and body weight (e) in the three experimental groups. The increase in total plasma levels of cholesterol was significantly decreased by the administration of EPA-E (c). However, other parameters were not affected by the administration of EPA-E (a, b, d, e). Data are expressed as mean ± SEM for eight mice. *P < 0.05 **P < 0.01, ***P < 0.001 vs. C57BL/6 J, #P < 0.05 ##P < 0.01 vs. KKAy-HF miceBack to article page